Subscribe

a website banner telling users to subscribe to it's newsletter

Breaking News

Regeneron Faces Lawsuit for Misreporting Eylea Prices to Medicare
Regeneron Faces Lawsuit for Misreporting Eylea Prices to Medicare Apr 15, 2024 The U.S. Department of Justice (DOJ) has initiated a lawsuit against Regeneron Pharmaceuticals under the False Claims Act (FCA), accusing the biotechnology company of fraudulently inflating Medicare reimbursement rates.
Glaukos Receives Permanent J-Code for iDose TR
Glaukos Receives Permanent J-Code for iDose TR Apr 04, 2024 Glaukos has announced the assignment of a unique, permanent J-code (J7355) by CMS for its iDose TR (travoprost intracameral implant) 75 mcg.
Researchers Introduce Algae-Derived Solution for Retinal Detachment
Researchers Introduce Algae-Derived Solution for Retinal Detachment Mar 26, 2024 A recent study has introduced an innovative approach to treating retinal detachment through an artificial vitreous body made from alginate, a natural carbohydrate extracted from algae.

 

Industry News

RevOpsis Therapeutics Secures $16.5M to Advance Wet AMD Treatment
RevOpsis Therapeutics Secures $16.5M to Advance Wet AMD Treatment Apr 26, 2024 RevOpsis Therapeutics has announced the successful closure of its first seed funding round, securing a total of $16.5 million.
Verana Health Launches Qdata Module for Thyroid Eye Disease Research
Verana Health Launches Qdata Module for Thyroid Eye Disease Research Apr 25, 2024 Verana Health has introduced its Qdata Thyroid Eye Disease (TED) module, a new addition to its suite of data solutions, featuring a comprehensive dataset derived from over 250,000 de-identified patients.
LEP Biomedical Secures Pre-Seed Funding to Advance HyaGuard Platform
LEP Biomedical Secures Pre-Seed Funding to Advance HyaGuard Platform Apr 25, 2024 LEP Biomedical announced pre-seed funding of €100,000 ($107,000) over two 6-month periods, which the company says will allow for further preclinical milestones in the development of the HyaGuard platform.

Ophthalmic Research News

Bausch + Lomb Announces Promising Results for Blink NutriTears in Dry Eye Study
Bausch + Lomb Announces Promising Results for Blink NutriTears in Dry Eye Study Apr 26, 2024 Bausch + Lomb has unveiled the results of a pivotal clinical study published in Frontiers in Ophthalmology, showcasing statistically significant efficacy and safety of their new daily nutritional supplement, Blink NutriTears.
New Study Links Visual Impairment to Increased Suicide Risk
New Study Links Visual Impairment to Increased Suicide Risk Apr 25, 2024 Researchers at Seoul National University Hospital in South Korea, led by Chung Young Kim, M.D., have conducted a comprehensive study exploring the link between visual impairment and various aspects of suicide.
Eye Tests Could Monitor Neurodegeneration in Parkinson’s Disease
Eye Tests Could Monitor Neurodegeneration in Parkinson’s Disease Apr 25, 2024 Researchers from the University of the Basque Country (UPV/EHU) and Biobizkaia have explored the potential of using a common ophthalmological tool, optical coherence tomography, to monitor neurodegeneration in patients with Parkinson’s disease.

Ophthalmic Blog

5 Dos and Don'ts After Laser Eye Surgery
5 Dos and Don'ts After Laser Eye Surgery Apr 25, 2024 Laser eye surgery has become a popular solution for correcting vision problems such as nearsightedness, farsightedness, and astigmatism.
Ocular Inflammation: Types, Causes, Diagnosis, and Treatment
Ocular Inflammation: Types, Causes, Diagnosis, and Treatment Apr 01, 2024 Ocular inflammation is a critical eye condition that can lead to discomfort, impaired vision, and, if left untreated, long-term damage to your eyesight.
Revolutionizing Eye Care: The Role of 3D Printing Today and Tomorrow
Revolutionizing Eye Care: The Role of 3D Printing Today and Tomorrow Mar 28, 2024 The ability of 3D bioprinting to fabricate complex tissue constructs holds the promise of overcoming limitations in current treatments and enhancing patient outcomes.
Ophthalmology Breaking News Subscribe